In a randomized controlled study, adding metformin to androgen deprivation therapy for low-tumor-volume metastatic hormone-sensitive prostate cancer significantly delayed development of castration-resistant disease.
The frequency of targetable alterations was roughly 22% in patients of African ancestry and those of European ancestry.
An analysis of data from the VA healthcare system revealed a gap in recommended assessments of cardiovascular risk factors among men with prostate cancer.
Retrospective study of more than 32,000 veterans sought to determine the incidence, management, and mortality of men with prostate cancer who experience depression.
Use of computed tomography and bone scans in low-risk prostate cancer cases has been in decline, but doctors continue to order these imaging modalities despite professional guidelines that do not recommend such use.
Interview study identifies men’s perception and concerns related to their prostate cancer journey.
The incidence of distant metastatic prostate cancer increased gradually over 2010 to 2015, investigators reported.
Men with ulcerative colitis may be particularly at risk for prostate cancer, according to researchers.
Men who undergo assisted reproduction have higher risk for prostate cancer, early-onset disease.
Nonadherence to protocol screenings in a screening trial for multiple cancers may be linked to higher overall mortality, excluding mortality due to cancers studied in the trial.
